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ABSTRACT: The acute oral toxicity of the anticoagulant rodenticide diphacinone was found to be about 20 times greater to
American kestrels (LD50=97 mg/kg) than to northern bobwhite (LD50=2,014 mg/kg). Several precise and sensitive clotting assays
(prothrombin time, Russell’s Viper venom time, thrombin clotting time) were adapted for use in these species, and this combination
of assays is recommended to detect effects of diphacinone and other rodenticides on coagulation. Oral administration of
diphacinone over a range of doses (sublethal to the extrapolated LD15) prolonged prothrombin time and Russell’s Viper venom time
within 24 to 48 hrs post-exposure. Prolongation of in vitro clotting time reflects impaired coagulation complex activity and was
detected before or at the onset of overt signs of toxicity and lethality. These data will assist in the development of a pharmacodynamic model to assess and predict rodenticide toxicity to non-target avian species.
KEY WORDS: anticoagulant, birds, clotting time, diphacinone, fibrinogen, non-target effects, prothrombin time, Russell’s Viper
venom time, secondary poisoning, thrombin clotting time
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INTRODUCTION
In the past 15 years, several current use anticoagulant
rodenticides have been identified as potential hazards to
predatory and scavenging birds, and adverse effects have
been reported in many countries (e.g., Newton et al. 1990,
Eason and Spurr 1995, Howald et al. 1999, Stone et al.
1999, 2003; Lambert et al. 2007, Walker et al. 2008,
Albert et al. 2009). For example, in the state of New
York between 1971 and 1997 there were at least 51
confirmed cases of death by hemorrhage with detection of
rodenticides in tissues of wildlife (Stone et al. 1999). A
surveillance program (1998 to 2001) reported that nearly
half of the 265 raptors examined had detectable quantities
of anticoagulant rodenticides in liver tissue, and these
compounds were considered the cause of death in about
15% of these cases (Stone et al. 2003). Many of the
incidents involved birds of prey, particularly great horned
owls (Bubo virginianus) and red-tailed hawks (Buteo
jamaicensis), that consume exposed or poisoned rodents.
The global magnitude of secondary poisoning by rodenticides in birds is unknown, as most events are probably
unnoticed or not reported.
A risk assessment by the U.S. Environmental Protection Agency (US EPA) identified several rodenticides
that pose a significant risk to birds and non-target
mammals (Erickson and Urban 2004), and subsequently
some restrictions were placed on the sale, distribution,
and packaging of brodifacoum, difethialone, bromadiolone, and difenacoum (US EPA 2008). This action may
be offset by expanded use of other anticoagulant rodent-

cides, including diphacinone. The hazard of diphacinone
to non-target organisms is inadequately characterized.
Accordingly, sublethal responses (blood clotting time)
and lethality were determined in northern bobwhite
(Colinus virginianus), a species traditionally used in wildlife pesticide risk assessments, and also in the American
kestrel (Falco sparverius), a well-studied toxicological
model for raptorial species (Bardo and Bird 2009).
Rather than using ad libitum dietary exposure in which
food consumption can be highly variable, a controlled
oral dosing regimen was employed to more accurately
estimate dose-related sublethal and lethal effect thresholds. These and other data will ultimately assist in the
development of a pharmacodynamic model of diphacinone in birds, and also in selection of efficacious baiting
strategies that may mitigate risk to non-target species.
METHODS
Animals
Adult northern bobwhite were obtained from R & R
Game Birds (Lamar, CO), housed individually in indoor
pens (61 cm × 46 cm × 33 cm high) at the USDA
National Wildlife Research Center, Fort Collins, CO
(NWRC), maintained in a 12 hr light:12 hr dark photoperiod at 18-21ºC, and provided food (Purina Game Bird
Maintenance Chow® Product 5440, 12.5% protein,
Denver, CO) and water ad libitum. Body weight of quail
ranged from 149-224 g. American kestrels were propagated in the captive colony of the USGS Patuxent
Wildlife Research Center, Laurel, MD (PWRC) (Porter
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and Wiemeyer 1970), where they were maintained in
outdoor flight pens (6.1 m × 2.4 m × 2.1 m high), and
provided daily rations of either Classic Bird of Prey diet
(Nebraska Brand, North Platte, NE) supplemented with
Vionate® (Gimborn US, Atlanta, GA), dead mice (Mus
musculus), or dead hatchling chickens (Gallus gallus),
and water. Body weight of kestrels ranged from 98-132
g.
Acute Toxicity of Diphacinone
An acute oral toxicity test was conducted in which
quail were gavaged with technical grade diphacinone
(99% active ingredient) (Hacco, Inc. Randolph, WI)
suspended in vegetable oil (Crisco®, Orville, OH). Doses
ranging from 917 to 3,666 mg/kg body weight (n = 9-10
quail/dose; about equal sex distribution/dose) were
selected through a stepwise process. Due to the low
solubility of diphacinone, birds in 4 of the treatment
groups received multiple doses within a 24-hr period
(total amount administered: 1,033 and 2,065 mg/kg – 2
doses/day; 2,868 mg/kg – 3 doses/day; and 3,666 mg/kg –
4 doses/day). The heaviest bird in a dosage group
received 1 ml of the suspension, and the remaining quail
in that group received a fraction of the volume
determined by their weight. Vegetable oil (vehicle) was
administered 1-3 times to 9 quail that served as controls.
Birds were observed twice daily for signs of toxicity for
14 days.
Using the results of the bobwhite acute toxicity test,
range finding trials with kestrels were undertaken.
Serious problems were encountered due to regurgitation
of diphacinone. Through an iterative process, a dosing
procedure was developed that minimized regurgitation.
In September and October 2009, kestrels were moved
from their flight pens to small outdoor cages (1.2 m × 0.8
m × 0.6 m high containing a rope perch, food tray, and
water bowl) where they were housed individually and fed
Classic Bird of Prey diet for at least a 10-day acclimation
period. Following an overnight fast, small quantities of
neat diphacinone (<200 mg/kg), freeze-dried bird of prey
diet, and 5 µl FD&C Blue #1 food dye (to better detect
regurgitation; McCormick & Co., Inc., Baltimore, MD)
were loaded into a number 4 gelatin capsule (E. Lilly and
Co., Indianapolis, IN) that was administered to the level
of the proventriculus using a pilling device (modified pet
piller, Jorgetsen Laboratories, Inc., Loveland, CO) and a
plastic probe. The capsule was chased with 0.2 ml of
distilled water by gavage, and the dosed kestrel was
returned to its pen and immediately presented with a
highly desired food item (i.e., dead chicken hatchling).
By repeating this procedure 4 times within a 24-hr period,
total daily dosages ranging from 35.1 to 675 mg/kg body
weight were achieved (n=19 kestrels, with sexes divided
near evenly among dosages, plus 4 controls that received
capsules containing only the freeze-dried diet and blue
dye). Pens were lined with kraft paper to monitor
regurgitation, and kestrels were observed for overt signs
of intoxication several times each day for a week.
Effects of Diphacinone on Clotting Time
Based upon the results of the acute toxicity test in
quail, another study was conducted in which bobwhite

were gavaged with either vegetable oil (control, n=6), 434
mg diphacinone/kg body weight (n=16), or 783 mg
diphacinone/kg (n=16). Quail were euthanized and immediately bled by cardiac puncture at 6, 12, 24, and 48
hrs post-dose, and controls were sacrificed and bled at 48
hrs post-dose. Blood samples (~0.5 ml) were collected
into syringes containing 50 µl of 0.5 M EDTA, a suitable
alternative to sodium citrate (Cerón et al. 2008). The
samples were centrifuged, plasma was harvested and
frozen at -80ºC, and subsequently shipped to PWRC for
analysis.
Using the aforementioned protocol from the kestrel
acute toxicity trial, another kestrel diphacinone study was
conducted in which a total of 50 mg/kg body weight was
administered as divided doses over a 24-hr period.
Controls were treated similarly except capsules did not
contain diphacinone. At 48 hrs after administration of the
final capsule, a 0.9-ml jugular venipuncture sample was
drawn into a syringe containing 0.1 ml of 3.2% sodium
citrate (n=3 diphacinone-treated and n=3 control kestrels),
and blood samples were collected from the remaining
birds (n=3 diphacinone-treated and n=2 controls) after
168 hrs. Blood samples were centrifuged and citrated
plasma was frozen at -80ºC for clotting time assays.

Figure 1. Blood coagulation pathway in birds (adapted from
Gentry 1993 and Thomson et al. 2002; F = Factor, PL =
phospholipid).

One-Stage Prothrombin Time Assay
An excess of tissue factor and phospholipid
(thromboplastin) interacts with plasma Factor VII to form
an active complex, and through a cascade of reactions
fibrinogen is eventually converted to fibrin which forms a
clot (Figure 1). Crude chick hatchling thromboplastin
(CHT) was prepared by the method of Quick as modified
by Griminger et al. 1970 and Doerr et al. 1975. The CHT
(50 mg) was suspended in 2,500 µl of 25 mM CaCl2, and
incubated at 42ºC for 15 min with intermittent vortexing.
Following centrifugation of the suspension (1,500 × g for
20 min), the supernatant was diluted (1:1) with 25 mM
CaCl2 (~220 µg protein/ml). Clotting time was determined using a BBL fibrometer (Becton Dickson & Co.,
Baltimore, MD). Plasma (100 µl) was incubated at 37ºC
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for 2 min, and the reaction was initiated by the addition of
200 µl of diluted CHT. Intra-assay precision (mean
coefficient of variation ± standard deviation) for duplicate
determinations of quail and kestrel plasma was 4.6 ±
4.5% (n=30) and 2.0 ± 2.2% (n=11), respectively. Interassay precision over the course of a year for human
reference samples using Simplastin® (rabbit brain
thromboplastin; Trinity Biotech, Berkeley Heights, NJ)
was 2.9 ± 2.2% (n=13). When a quail or a kestrel plasma
pool was diluted with 8.3 mM Na/K phosphate buffer
(pH 7.2), clotting time was relatively stable at dilutions
containing as little as 50% plasma, but increased at
greater dilution.
Russell’s Viper Venom Time (RVVT)
Russell’s Viper venom (RVV) directly activates
Factor X (but not Factor VII ) in the common pathway of
the clotting cascade (Figure 1). Reconstituted RVV
Factor X activator (American Diagnostica, Stamford, CT)
was diluted 1:10 with imidazole buffered saline (IBS;
0.0125 M imidazole 0.109 M NaCl, pH7.4) and maintained at room temperature. Plasma (100 µl) was incubated at 37ºC in a sample cup for 2 min, and 100 µl of
diluted RVV was added and incubated for 15 sec. The
reaction was initiated with 100 µl 25 mM CaCl2, and
clotting time was determined (Triplett and Harms 1981a).
Intra-assay precision for duplicate determinations of quail
plasma was 6.5 ± 13.5% (n=19) and kestrel plasma was
3.4 ± 4.1% (n=9). Clotting time remained relatively
stable when quail or kestrel plasma was diluted by as
much as 60% with phosphate buffer, but RVVT increased
dramatically at greater dilutions.
Thrombin Clotting Time (TCT)
This assay measures the time for conversion of
fibrinogen to fibrin (Figure 1) using a standard thrombin
solution (Triplett and Harms 1981b). The assay is an
indicator of the amount of fibrinogen in the plasma
sample, and insensitive to deficiency of vitamin Kdependent clotting factors.
We used the AMAX
Fibrinogen kit (Trinity Biotech) which includes bovine
thrombin reagent and human fibrinogen reference material. A fibrinogen standard curve was prepared (65 to
520 mg/dL), and quail or kestrel plasma samples were
diluted 1:10 with IBS. Diluted plasma (200 µl) was
incubated at 37ºC in a sample cup for 2 min, and the
reaction initiated by the addition of 100 µl of thrombin
reagent. Clotting time of the test sample was transformed
to fibrinogen concentration (mg/dL) from the standard
curve. Intra-assay precision for duplicate determinations
of quail plasma was 5.7 ± 6.8% (n=32) and kestrel
plasma was 1.8 ± 2.2% (n=9).
Statistical Methods
For the acute toxicity trial, the median lethal dose
(LD50) of diphacinone in bobwhite and kestrels was
estimated using probit analysis (SAS Institute, Carey,
NC). For sublethal dosing studies, prothrombin time,
RVVT, and TCT were tested for homogeneity of variance
(Fmax test) and normality (Shapiro-Wilk test, normal
probability plot and descriptive statistics). The measurement endpoints were then compared by one-way analysis

of variance (ANOVA) in the quail study and by a 2 × 2
factorial ANOVA (dosage × time) in the kestrel study.
Tukey’s HSD test was used as a mean separation procedure.
RESULTS
Acute Toxicity Studies
Survival of northern bobwhite was significantly
related (P < 0.0001) to dose of diphacinone (survivors: 9
of 10 at 917 mg/kg; 8 of 9 at 965 mg/kg; 10 of 10 at
1,033 mg/kg; 7 of 10 at 2,065 mg/kg; 1 of 10 at 2,868
mg/kg; 0 of 10 at 3,666 mg/kg). Bobwhite receiving the
greatest doses (2,868 and 3,666 mg/kg) succumbed
within 1-3 days of exposure. Some dosed quail exhibited
subcutaneous bruises on the breast and back regions
which could reflect coagulopathy; however, there was no
evidence of frank internal or external bleeding. All
vehicle-dosed controls survived the 14-day trial. The
LD50 estimate was 2,014 mg/kg (95% confidence interval
1,620-2,475 mg/kg), and the slope of the dose-response
curve was steep (probit/log10 ± SE = 9.92 ± 2.27).
Survival of American kestrels was also significantly
related (P < 0.023) to dose of diphacinone (survivors: 2 of
2 at both 35.1 and 52.7 mg/kg, 2 of 3 at 79.0 mg/kg, 0 of
3 at 118.6 mg/kg, 0 of 2 at 177.8 mg/kg, 0 of 1 at 200
mg/kg, 1 of 1 at 266.7 mg/kg, 0 of 2 at 300 mg/kg, 0 of 1
at both 450 and 675 mg/kg). Sample size for two
intermediate doses was only 1, as a bird scheduled to
receive 266.7 mg/kg died before the final capsule
containing its divided dose could be administered. Birds
scheduled to receive 600 and 900 mg/kg died before the
final divided dose could be given, so the actual
administered doses were 450 and 675 mg/kg. Kestrels
that succumbed appeared to exhibit a progression of toxic
signs (loss of balance on perch, standing on floor of pen
rather than perch, non-reactive when approached,
subdued behavior, appearance of tan urate deposits) and
died between 10 to 48 hrs after receiving the initial
capsule of the divided dose. Two kestrels (266.7 and 79.0
mg/kg doses) exhibited toxic signs, but appeared to
recover by the third day of the trial. All controls survived
the 7-day trial. The LD50 of diphacinone for kestrels was
estimated to be 97 mg/kg (95% confidence interval 38219 mg/kg), and the slope of the dose-response curve was
6.69 ± 2.94 probit/log10.
Sublethal Exposure and Effects on Clotting Time
In the quail study, the 434 mg/kg dose was slightly
greater than the lower 95% confidence limit of the LD01,
while the 783 mg/kg dose fell between the estimated LD01
and LD02. Both of these doses prolonged clotting time
when compared to controls, but the temporal response
was highly variable (e.g., see scatter of prothrombin times
in Figure 2). However, fibrinogen concentration in 5
samples as determined in the TCT assay was undetectable, and the volume of another sample was too small to
determine fibrinogen concentration. The absence of
fibrinogen in these samples suggest that they may have
been collected improperly (viz., cardiac puncture of
euthanized birds, partially clotted blood). Fibrinogen is
generally in great excess, and its conversion to fibrin in
the TCT assay is not influenced by vitamin K antagonists.
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Figure 2. Prothrombin time (mean ± standard deviation;
 = data point) of all quail gavaged with vehicle (control)
or at 6, 12, 24, and 48 hrs following administration of
diphacinone.

Figure 3. Prothrombin time of quail gavaged with vehicle
(control) or diphacinone (6, 12, 24, and 48 hrs post-dose)
with plasma fibrinogen concentration >60 mg /dL.
* = significantly different (P < 0.05) than control.

When these 6 samples were excluded, the remaining
samples contained more than 60 mg fibrinogen/dL
(range: 63 to 254 mg/dL, n=32). For these remaining
samples, prothrombin time and RVVT (Figures 3 and 4)
were prolonged about three- to four-fold (P < 0.05) at 48
hrs after administration of 434 mg/kg, and similarly
prolonged by 783 mg/kg at both 24 hrs and 48 hrs (P <
0.05), when compared to the control group.
In the kestrel study, the 50 mg/kg dose fell between
the estimated LD10 and LD15, and all birds survived the
trial. However, one diphacinone-dosed kestrel was
subdued on days 2 and 3, and before it was bled a
subcutaneous hematoma was observed on its neck. A
significant dose × time interaction was detected by
ANOVA for both prothrombin time (P < 0.023) and
RVVT (P < 0.027). Diphacinone prolonged prothrombin
time (P < 0.036) and RVVT (P < 0.032) in blood samples
collected 48 hrs after administration of the final capsule
of the divided dose, but after 7 days clotting times
returned to control values (Figures 5 and 6). Fibrinogen
concentration was detectable in all samples (range: 45 to
147 mg/dL) and did not differ (P > 0.15) among the 4
groups.

Figure 5. Prothrombin time of kestrels administered 4
capsules containing diphacinone (50 mg/kg over 24 hrs
in divided doses) or capsules without rodenticide
(control) at 48 and 168 hrs post-dose.
* = significantly different (P < 0.05) than concurrent control.

*

Figure 4. Russell’s Viper venom time of quail gavaged with
vehicle or diphacinone (6, 12, 24, and 48 hrs post-dose)
with plasma fibrinogen concentration >60 mg /dL.
* = significantly different (P < 0.05) than control.

Figure 6. Russell’s Viper venom time of kestrels
administered 4 capsules containing diphacinone (50
mg/kg over 24 hrs in divided doses) or capsules without
rodenticide (control) at 48 and 168 hrs post-dose.
* = significantly different (P < 0.05) than concurrent control.
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DISCUSSION
Diphacinone may be categorized as only slightly toxic
(LD50 2,014 mg/kg) to northern bobwhite using traditional categories that classify harm (Loomis 1978). A
reliable diphacinone median lethal dose for bobwhite
could not be estimated in a previous study (Campbell et
al. 1991) as dosages were separated by a factor of 5, but
inspection of the data suggest that the theoretical value
fell between 400 and 2,000 mg/kg (US EPA 1998). Our
estimated LD50 in quail is of the same order of magnitude
as reported for mallards (Anas platyhrynchos; 3,158
mg/kg) (Erikson and Urban 2004). Based upon data from
avian species commonly used in pesticide registration
tests (viz., northern bobwhite, mallards), diphacinone
appears to be less toxic to captive birds than to laboratory
rats and domesticated mammals (range of estimated
LD50: 0.8 to 15 mg/kg), and to wild mammals (0.2 to 340
mg/kg), and its risk to wild birds would seemingly be
minimal (reviewed in Erikson and Urban 2004, Eisemann
and Swift 2006). However, results of the diphacinone
acute toxicity test in American kestrels (LD50 97 mg/kg)
indicate that they are over 20 times more sensitive than
bobwhite, and over 30 times more sensitive than
mallards. Furthermore, a small dosing trial in which
diphacinone-poisoned mice (Peromyscus maniculatus)
were fed to great-horned owls (Buto virginianus) and a
saw-whet owl (Aegolius acadicus) also suggests that they
are more sensitive than bobwhite (Mendenhall and Pank
1980). Notably, diphacinone has been linked to secondary poisoning in raptors (Stone et al. 1999, 2003), and in
general, raptors are more sensitive to pesticides than other
groups of birds (Wiemeyer and Sparling 1991, Vyas et al.
1998, Mineau et al. 1999). These findings indicate that
extrapolation of diphacinone toxicity data from quail and
mallards to other avian Orders (e.g., Falconiformes,
Stringiformes) may be dubious, and protection of raptors
may require substantial safety factors.
Some kestrels that survived dosing trials exhibited
behavioral changes (e.g., 1 dosed at 266.7 mg/kg, and 1
of 3 dosed at 79.0 mg/kg) and prolonged clotting time (2
of 3 dosed at 50 mg/kg). Similarly, golden eagles (Aquila
chrysaetos) fed muscle from sheep dosed with diphacinone (30 mg/kg) were weakened and debilitated and
had prolonged prothrombin time (Savarie et al. 1979). In
both of these studies animals recovered, but such
behavioral and physiological deficits could affect survival
of free-ranging birds.
Several coagulation assays were adapted that yielded
short and precise clotting times with EDTA-treated plasma from quail and citrated plasma from kestrels. Using a
thromboplastin extract from chick hatchlings, prothrombin time of untreated quail (mean ± standard deviation:
15.2 ± 1.5 sec, Figure 3) and kestrels (10.6 ± 0.8, Figure
5) was in the range of values reported for many species of
domesticated and wild birds (Martin et al. 1994, reviewed
in Powers 2000, Thomson et al. 2002, Morrisey et al.
2003, Rattner et al. 2009, Webster 2009). Using RVV
that activates Factor X in the common pathway, clotting
time of plasma from untreated quail (39.5 ± 8.9 sec,
Figure 4) and kestrels (22.6 ± 2.8, Figure 6) was slightly
greater than reported in other avian species (~9 to 21 sec;
Tahira et al. 1977, Timms 1977), although precision for

duplicate RVVT determinations and standard deviation of
control samples with >45 mg fibrinogen/dL, seems acceptable.
Anticoagulant rodenticides inhibit vitamin Kdependent post-translational processing of clotting
Factors II (prothrombin), VII, IX, and X (reviewed in
Powers 2000), but do not affect the synthesis of
fibrinogen. Fibrinogen deficiency resulting from improper sample collection and from pathophysiologic
conditions (e.g., hepatic synthetic failure, disseminated
intravascular coagulation) can prolong in vitro clotting
time. Avian studies examining anticoagulant rodenticide
toxicity have failed to determine if sample fibrinogen
content supports in vitro clot formation. A concentration
threshold that supports clotting has yet to be established
for birds, and in the interim, we used 60 mg/dL in quail
and 45 mg/dL in kestrels. A conservative diagnostic
approach for anticoagulant rodenticide studies that
evaluate vitamin K-dependent coagulopathies would
entail a combination of assays, namely prothrombin time
and/or RVVT, plus determination of fibrinogen (TCT) to
rule out any nonspecific influence on clotting time.
In the present study, several quail plasma samples did
not contain detectable quantities of fibrinogen, failed to
clot in both the in vitro one-stage prothrombin time and
RVVT assays, and thus were excluded from our
evaluation of diphacinone on hemostasis in quail.
Clotting time of samples with detectable fibrinogen was
not affected at 6 and 12 hrs after administration of
diphacinone, but was prolonged at 24 and 48 hrs postdose. In kestrels, effects on clotting time were apparent at
48 hrs after administration of the final divided dose of
diphacinone. This time course roughly corresponds with,
and may precede, the onset of overt toxicity and lethality
at greater dosage levels used in the acute toxicity studies.
The lag time between dosing and development of
coagulopathy reflects the half-life clearance of functional
coagulation factors and the increasing circulation of descarboxy, dysfunctional factors. Prothrombin time is used
as an early indicator of anticoagulant rodenticide
ingestion in domestic mammals (Mount and Feldman
1983), and is routinely measured to monitor coumadin
anticoagulant therapy in humans (Spinler et al. 2005).
Prolonged prothrombin times have been reported within
days of 1) dietary exposure to the anticoagulant
rodenticides diphacinone (golden eagles, Savarie et al.
1979; American crow, Corvus brachyrhynchos, Massey
et al. 1997), warfarin (chickens, Veltmann et al. 1981)
and brodificoum (Japanese quail, Coturnix coturnix,
Webster 2009), and 2) repeated gavage with pindone
(wedge-tailed eagles, Aquila audax, bronzewing pigeons,
Phaps chalcoptera, Port Lincoln parrots, Barnardius
zonarius, black ducks, Anas supercillosa, Australian
magpies, Gymnorhina tibicen, Martin et al. 1994).
In conclusion, diphacinone was found to be considerably more toxic to American kestrels than to northern
bobwhite. A group of clotting assays were developed and
applied for use in quail and kestrels that are sensitive,
precise, linked to the pathogenesis of toxicity (and
ultimately mortality), and together have applicability as
biomarkers in both laboratory studies and field
monitoring. These findings and assay methods will assist
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in rodenticide hazard and risk assessments of secondary
poisoning in non-target avian species.
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